-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Initiates Coverage On Q32 Bio with Buy Rating, Announces Price Target of $13

Benzinga·02/25/2026 12:04:30
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Buy rating and announces Price Target of $13.